This year’s chemistry Nobel Prize has been awarded to Dr Venki Ramakrishnan of LMB for “studies of the structure and function of the ribosome”. Venki Ramakrishnan shares the honour with Thomas A. Steitz (Yale University) and Ada E. Yonath (Weizmann Institute of Science, Israel). The trio showed how the information encoded on strands of DNA […]
LMB News
Human Antibodies developed for Treatment of Lupus and Anthrax
Two therapies with their roots in antibody technology developed in the LMB and the Scripps Research Institute* have recently emerged as promising new drug candidates to treat lupus, a potentially fatal autoimmune disease, and anthrax, a pressing concern due to bioterrorism. The drug candidates—belimumab (BENLYSTATM, formerly LumphoStat-B®), developed by Human Genome Sciences with GlaxoSmithKine as […]